Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interleukin-10-secreting regulatory T cells (Tr1 cells) are a subset of regulatory T cells that suppress immune responses primarily through the secretion of interleukin-10 (IL-10). They are induced in the periphery under tolerogenic conditions and play a crucial role in maintaining immune tolerance, preventing autoimmunity, and modulating inflammation. Unlike naturally occurring CD4+CD25+FOXP3+ Tregs, Tr1 cells do not constitutively express FOXP3.
IL-10 mediated immunosuppression
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin-10-Secreting Regulatory T Cell (Tr1).